Do you want to read an article? Please log in or register.
Disease course and symptoms in smoking versus non-smoking patients with Celiac disease
Celiac Disease
COMMENTED
Related content
RECOMMENDED
Celiac Disease
Gastrointestinal and Extraintestinal Symptoms among Celiac Disease Patients Undergoing a Dose Specified Gluten Challenge: a Systematic Review and Meta-Analysis
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Banegas M, Marin DF, Naskar N, Correa TL, Rotman C, Regis S, Simpson A, Chang D, Silvester J, Therrien A
doi: 10.14309/ajg.0000000000003506
Gastroesophageal Reflux Disease (GERD)
Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Non-Erosive Reflux Disease
Am J Gastroenterol
Antunes C, Ghosh G, Katz P, Yadlapati R, Leifke E, Harris T, Graham H, Laine L
doi: 10.14309/ajg.0000000000003794
Celiac DiseaseIrritable Bowel Syndrome (IBS) and Chronic Constipation
Global prevalence of celiac disease in patients with Rome III and Rome IV irritable bowel syndrome: A systematic review and meta-analysis
Am J Gastroenterol
Shiha MG, Schiepatti A, Manza F, Maimaris S, Aziz I, Sanders DS
doi: 10.14309/ajg.0000000000003586
Further Publications
Perianal Disease in Pediatric-Onset Crohn's Disease: Incidence, Disease Course, and Long-Term Outcomes
Clin Gastroenterol Hepatol
Ström A, Jansson S, Wewer MD, Burisch J, Malham M, Wewer V
doi: 10.1016/j.cgh.2025.05.015
RECOMMENDED
Inflammatory Bowel DiseaseFurther Publications
Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gut
Miyauchi E, Taida T, Uchiyama K, Nakanishi Y, Kato T, Koido S, Sasaki N, Ohkusa T, Sato N, Ohno H
doi: 10.1136/gutjnl-2025-334922
Gastrointestinal CancerHepatology
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
Gut
Lai JC, Yang B, Lee HW, Lin H, Tsochatzis EA, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Duràn R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castera L, Lai M, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, Saint-Loup M, Llop E, Teh KKJ, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gómez M, Kim SU, Wong VW, Yip TC
doi: 10.1136/gutjnl-2025-334981
Esophagus Diseases
Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial
Lancet Gastroenterol Hepatol
Takeuchi H, Machida R, Ando M, Tsubosa Y, Kikuchi H, Kawakubo H, Noma K, Ueno M, Tsushima T, Bamba T, Fujita T, Hamai Y, Kakishita T, Daiko H, Koyanagi K, Matsuda S, Kato K, Sasaki K, Kita R, Kitagawa Y, JCOG1409 investigators
doi: 10.1016/S2468-1253(25)00207-9
Inflammatory Bowel Disease
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study
J Crohns Colitis
Roblin X, Vieujean S, Nancey S, Hebuterne X, Arab-Hocine N, Savoye G, Viennot S, Bouguen G, Fumery M, Duru G, Botelho-Nevers E, Berger AE, Tardy B, Mathieu N, Barrau M, Peyrin-Biroulet L, Paul S
doi: 10.1093/ecco-jcc/jjaf115
Esophagus DiseasesGastroesophageal Reflux Disease (GERD)
VALIDATION OF ESOPHAGEAL GLOBAL SYMPTOM SEVERITY AS A PATIENT REPORTED OUTCOME FOR EVALUATION OF REFLUX SYMPTOMS
Am J Gastroenterol
Chan WW, Schroeder M, Richardson A, Shah N, Muftah M, Muftah S, Siboni S, Sozzi M, Wong MW, Chen CL, Gyawali CP, Milan Score Working Group
doi: 10.14309/ajg.0000000000003499